Published: Mar 25, 2026
Written by Klarity Editorial Team
Published: Mar 25, 2026

If you’re living with bipolar disorder, accessing consistent psychiatric care can feel overwhelming—especially when juggling work schedules, transportation barriers, or simply finding a provider who’s accepting new patients. The good news? Telehealth has transformed mental health treatment, making it possible to receive professional bipolar care from home. But one critical question remains: Is it actually legal to get bipolar medications prescribed online?
The short answer is yes—with important nuances. As of 2025, federal and state laws allow licensed psychiatrists, nurse practitioners, and other qualified providers to prescribe common bipolar medications like Lithium, Lamictal (lamotrigine), and Seroquel (quetiapine) through telehealth in all 50 states. Unlike controlled substances such as ADHD stimulants, these mood stabilizers face no special federal restrictions for telemedicine prescribing.
This guide breaks down everything you need to know: current telehealth laws, state-specific rules, which medications qualify, what to expect during a virtual visit, and how to find safe, legitimate online psychiatric care.
When discussing online prescribing, you’ll often hear about the Ryan Haight Act—a 2008 federal law designed to prevent illegal online pharmacies from dispensing controlled substances (like opioids or stimulants) without proper medical evaluation. Here’s what matters for bipolar treatment:
Lithium, Lamotrigine, and Quetiapine are NOT controlled substances. These medications fall outside the DEA’s scheduling system, meaning the Ryan Haight Act’s in-person examination requirement never applied to them. Federal law has always permitted telehealth prescribing of non-controlled psychiatric medications, provided the prescriber follows standard medical practice.
While bipolar mood stabilizers aren’t affected, it’s worth understanding the broader telehealth landscape. The DEA has temporarily extended COVID-era flexibilities allowing controlled substance prescriptions (like Adderall or Xanax) via telehealth through December 31, 2026—without requiring an initial in-person visit. This extension ensures continuity of care while the DEA finalizes permanent telemedicine regulations.
Key takeaway: If your bipolar treatment plan includes a controlled medication (such as a benzodiazepine for anxiety), your provider can still prescribe it via telehealth under current federal rules—but be aware these flexibilities are temporary and subject to change.
While federal law sets the baseline, each state regulates telehealth practice within its borders. The good news: no state prohibits telehealth prescribing of non-controlled bipolar medications as of 2025. However, some states have specific requirements:
Most states—including California, Texas, New York, Florida, Delaware, Pennsylvania, Illinois, Georgia, and Alabama—allow providers to prescribe Lithium, Lamotrigine, and Quetiapine after a comprehensive telehealth evaluation. No in-person visit is required before or during treatment, as long as the video consultation meets the standard of care.
California has been particularly progressive, with proposed legislation (AB 1503) that would explicitly allow asynchronous screening tools as part of telehealth assessments—though live video remains the gold standard for bipolar evaluations.
New York adopted new controlled-substance rules in May 2025 requiring in-person visits for certain controlled drugs, but these rules do not affect non-controlled mood stabilizers.
New Hampshire takes a middle-ground approach: providers can initiate treatment via telehealth, but patients receiving ongoing prescriptions must have at least one evaluation (which can be virtual) every 12 months. This applies even to non-controlled medications, ensuring continuity of care and safety monitoring.
Your prescriber doesn’t have to be a psychiatrist. Many states grant Nurse Practitioners (NPs) independent prescribing authority for bipolar medications:
Full Independent Practice (30+ states): In states like New York, Delaware, New Hampshire, and Arizona, experienced NPs can evaluate, diagnose, and prescribe mood stabilizers without physician oversight.
Collaborative Practice (Texas, Florida, Pennsylvania, etc.): NPs must work under a formal agreement with a supervising physician—but can still manage bipolar treatment independently within that framework. These collaborative agreements don’t restrict access; they’re administrative arrangements between providers.
California is transitioning: NPs with advanced training can now practice independently under AB 890, with full implementation by 2026.
Bottom line: Whether you see an MD, DO, or NP via telehealth, as long as they’re licensed in your state and authorized to prescribe, you can legally receive bipolar medication.
These medications are the backbone of bipolar treatment and can be prescribed via telemedicine in all states:
Lithium (Lithium Carbonate)
Lamictal (Lamotrigine)
Seroquel (Quetiapine)
Anticonvulsants like Depakote (valproic acid), Tegretol (carbamazepine), and Trileptal (oxcarbazepine) are also non-controlled and legally prescribable via telehealth. Atypical antipsychotics such as Abilify (aripiprazole), Latuda (lurasidone), and Vraylar (cariprazine) follow the same rules.
If your treatment plan includes a controlled medication—such as benzodiazepines (Klonopin, Ativan) for acute anxiety—these can currently be prescribed via telehealth under the DEA’s temporary extension through 2026, though long-term access depends on upcoming federal rulemaking.
Legitimate online psychiatric care isn’t a shortcut—it’s a comprehensive clinical process conducted remotely. Here’s how a typical telehealth bipolar assessment works:
You’ll complete detailed questionnaires about your mental health history, mood episodes, family history, current symptoms, and any medications or substances you use. Many platforms use validated screening tools (like the Mood Disorder Questionnaire) to guide the evaluation.
A licensed psychiatrist or psychiatric nurse practitioner will conduct a thorough diagnostic interview via secure video. Expect questions about:
The provider will observe your presentation—speech patterns, mood, thought process—to complete a mental status exam, just as they would in person.
If bipolar disorder is diagnosed (per DSM-5 criteria), the provider will discuss treatment options: medication, psychotherapy referrals, lifestyle modifications, and follow-up schedules. They’ll explain risks, benefits, and what to monitor for side effects.
If medication is appropriate, the prescription is sent electronically to your chosen pharmacy (required by law in many states). For Lithium, you’ll also receive lab orders for baseline tests—you’ll go to a local lab or use at-home testing if available.
Bipolar disorder is chronic. Your provider will schedule follow-ups (often every 4–12 weeks initially, then quarterly once stable) to assess mood symptoms, medication response, and lab results. These check-ins can typically be done via telehealth, though your provider may request an in-person visit if complications arise.
Prescription Drug Monitoring Programs (PDMPs) are state databases that track controlled substance prescriptions. Here’s what you should know:
For non-controlled bipolar meds (Lithium, Lamictal, most antipsychotics): PDMP checks are not legally required in any state, since these drugs aren’t controlled substances. However, many providers check the database anyway as a safety measure—especially for Seroquel, which some states flag due to misuse potential.
For controlled meds (benzodiazepines, stimulants): Prescribers must check the PDMP before prescribing in most states (Texas, Florida, New York, etc.). This helps identify dangerous drug combinations or ‘doctor shopping.’
Patient perspective: PDMP checks protect you. They allow your provider to see if you’re taking other psychiatric meds that could interact, or if a previous prescriber started you on something that might complicate bipolar treatment.
The explosion of online mental health services has brought both innovation and bad actors. Here’s how to identify quality care:
At Klarity Health, providers are rigorously credentialed, state-licensed, and required to follow evidence-based diagnostic protocols. Patients undergo thorough video evaluations, and treatment plans include ongoing monitoring—because sustainable mental health care requires partnership, not quick fixes. Klarity accepts both insurance and transparent cash-pay rates, ensuring affordability without compromising clinical standards.
Not when done correctly. Disreputable companies (like Done and Cerebral, which faced federal charges in 2024 for fraudulent ADHD prescribing) abused telehealth by issuing controlled substances with minimal oversight. However, legitimate telehealth psychiatry follows the same diagnostic criteria and documentation standards as in-person care. For bipolar disorder—where misdiagnosis or incorrect medication can be dangerous—ethical providers take evaluation seriously. You’ll spend more time in a quality telehealth intake than many rushed in-office visits.
Absolutely. Medication is one pillar of bipolar treatment; psychotherapy (especially Cognitive Behavioral Therapy or Interpersonal and Social Rhythm Therapy) is equally important for managing triggers, sleep schedules, and coping skills. Most telehealth psychiatry platforms can refer you to therapists, or you can find one separately. Klarity’s providers emphasize integrated care, often coordinating with your therapist to ensure holistic treatment.
Telehealth has limits. If you’re experiencing severe mania, active psychosis, or acute suicidal ideation, your provider may refer you to in-person emergency care or an inpatient facility. Telehealth works best for stable-to-moderate bipolar disorder and ongoing maintenance. Always be honest about symptom severity—your provider will triage appropriately.
HIPAA protections apply equally to telehealth. Your provider cannot disclose your diagnosis or treatment without your consent (except in limited safety situations). If you use insurance, your plan will see claims like any other medical service. Many patients prefer cash-pay for added privacy—Klarity offers both options.
While non-controlled bipolar medications remain unaffected, the DEA is drafting permanent regulations for controlled substance telemedicine (expected in late 2025 or 2026). Proposed rules may require ‘special telemedicine registration’ for providers prescribing Schedule II–V drugs across state lines. Congress is also considering the Telehealth Modernization Act, which would codify COVID-era flexibilities into law.
Impact on bipolar patients: If your treatment includes benzodiazepines or stimulants (for comorbid ADHD), watch for rule changes. Providers like Klarity stay ahead of regulatory shifts to ensure uninterrupted access.
Several states are advancing full practice authority for nurse practitioners. Pennsylvania has pending legislation (as of 2025) to allow NPs to prescribe independently; if passed, it would expand access to psychiatric care statewide. California’s AB 890 implementation continues, with more NPs gaining autonomy through 2026.
Why it matters: Greater NP independence means shorter wait times and more affordable care—NPs often charge less than psychiatrists while providing equivalent quality for medication management.
Emerging platforms combine telehealth with app-based mood tracking, medication reminders, and peer support. While these tools don’t replace clinical care, they enhance engagement and help providers monitor patterns between visits.
If you’re ready to explore online psychiatric treatment, here’s a roadmap:
Verify your state’s laws: Use the state table in this guide to confirm telehealth is allowed where you live (it is for mood stabilizers nationwide, but check for nuances).
Gather your medical history: Compile any previous psychiatric records, medication lists, and recent lab results (if available). This speeds up your evaluation.
Choose a reputable platform: Look for transparent pricing, state-licensed providers, and comprehensive intake processes. Klarity Health offers same-week appointments with board-certified psychiatric providers, accepts insurance, and provides ongoing care coordination—not just one-time prescriptions.
Prepare for your first visit: Be ready to discuss your mood history honestly, including manic and depressive episodes, sleep patterns, and any substance use. The more information you provide, the more accurate your diagnosis and treatment plan.
Commit to follow-up: Bipolar disorder requires ongoing management. Schedule regular check-ins, get your labs done on time (especially for Lithium), and communicate any side effects or mood changes promptly.
Telehealth has democratized access to bipolar disorder treatment, removing barriers like geography, transportation, and provider shortages. Yes, you can legally and safely get bipolar medications prescribed online in 2025—Lithium, Lamotrigine, Quetiapine, and other mood stabilizers are fully permitted for telemedicine prescribing under federal and state law.
But legality is just the baseline. Quality care requires partnership: a thorough evaluation, evidence-based treatment, regular monitoring, and open communication between you and your provider. Whether you choose an in-person psychiatrist or a telehealth platform like Klarity, the principles remain the same—accurate diagnosis, appropriate medication, integrated therapy, and sustained engagement.
If bipolar disorder has felt isolating or overwhelming, telehealth offers a lifeline. With the right provider, you can build stability, manage symptoms, and reclaim your well-being—all from the comfort of home.
Ready to take the first step? Klarity Health connects you with experienced psychiatric providers who specialize in mood disorders. Our platform offers transparent pricing (insurance accepted), flexible scheduling, and comprehensive care that goes beyond a prescription. Book a consultation today and start your journey toward balanced, sustainable mental health.
U.S. Department of Health and Human Services. ‘HHS & DEA Extend Telemedicine Flexibilities Through 2026.’ HHS Press Release, January 2, 2026. www.hhs.gov
Drug Enforcement Administration. ‘DEA Extends Telemedicine Flexibilities to Ensure Continued Access to Care.’ DEA Press Release, December 31, 2025. www.dea.gov
Sheppard Mullin Richter & Hampton LLP. ‘Telehealth and In-Person Visits: Tracking Federal and State Updates.’ JD Supra, August 15, 2025. www.jdsupra.com
Texas Board of Nursing. ‘APRN Frequently Asked Questions – Prescriptive Authority.’ Texas Board of Nursing Official Guidance, accessed December 2025. www.bon.texas.gov
NursePractitionerOnline.com. ‘Nurse Practitioner Practice Authority Updates: 2025 State-by-State Analysis.’ Professional Education Resource, October 3, 2025. www.nursepractitioneronline.com
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Bipolar disorder is a serious mental health condition requiring professional diagnosis and treatment. Always consult a licensed healthcare provider before starting, stopping, or changing psychiatric medications. If you are experiencing a mental health crisis, call 988 (Suicide & Crisis Lifeline) or go to your nearest emergency room.
Find the right provider for your needs — select your state to find expert care near you.